Kollet is responsible for project leadership, analysis and the development of NHF’s healthcare payer education strategies, policies and programs, including the Comprehensive Care Sustainability Collaborative (CCSC). Prior to her tenure at NHF, Kollet served as the Executive Director of the Bleeding & Clotting Disorders Institute in Peoria IL, a federally recognized Hemophilia Treatment Center(HTC) of Excellence, where she developed and grew an inhouse specialty pharmacy program that became one of the larger programs in the country. Kollet has also served on the Hemophilia Alliance Executive Board of Directors, served as the chair of the national payer subcommittee and sat on the Illinois Hemophilia Advisory board. With hemophilia ranking #12 of 20 for highest cost catastrophic claims, #9 for reported high cost claims for stop loss carriers and #8 of 10 highest cost claims for jumbo employer sponsored health plans ; Kollet strongly believes that the stage is set for all parties who share in the cost risks associated with rare chronic disorders, to change their current practice of giving away their healthcare brainpower to those who might have experience with specialty pharmacy dispensation for these chronic rare diseases, without at least entering into dialogue with those that are the experts in managing this patient population.